Blog - Page 520 of 5683 - QualityStocks

TuesdayApr 02, 2024 3:01 pm

QualityStocksNewsBreaks – Danimer Scientific Inc. (NYSE: DNMR) Secures ~$15M in Registered Direct

Danimer Scientific (NYSE: DNMR) is a leading next- generation bioplastics company focused on the development and production of biodegradable materials. The company recently announced the closing of its registered direct offering for the purchase and sale of 15,000,000 shares of common stock (or common stock equivalent in lieu thereof) at a purchase price of $1.00 per share (or per common stock equivalent in lieu thereof) and accompanying warrants to purchase up to an aggregate of 15,000,000 shares of common stock. Danimer secured approximately $15 million in gross proceeds, of which it intends to use the net for working capital and…

TuesdayApr 02, 2024 2:49 pm

QualityStocksNewsBreaks – HealthLynked Corp. (HLYK) Releases Q4, FY 2023 Financial Report Reflect Focus on Core Healthcare Network

HealthLynked (OTCQB: HLYK), a leader in healthcare networking and technological innovation, is reporting financial results for Q4 and full year ended Dec. 31, 2023. A highlight of the report includes that, based on “strategic advancements and its focus on core healthcare technologies and networking capabilities, HealthLynked achieved a significant 70% reduction in net loss for the fourth quarter, highlighting a period of fiscal management and strategic positioning for future growth.” The report noted that the company’s strategic focus and technological innovations are paving the way for an optimistic outlook with optimization of operational expenses leading to a 52% cut in operational losses. In…

TuesdayApr 02, 2024 1:35 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Positive Preclinical Data Supporting NPRL2 Gene Therapy

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company today announced that its research collaborators have published positive preclinical data for the NPRL2 tumor suppressor gene, utilizing Genprex’s non-viral Oncoprex(R) Delivery System, in KRAS/STK11 mutant anti-PD1 resistant non-small cell lung cancer (“NSCLC”) in a humanized mouse model. “These positive preclinical data are very encouraging and support NPRL2 gene therapy as a potential treatment for a sub-group of NSCLC in which patients traditionally are resistant to existing therapies,” said Rodney Varner, president, chairman and CEO at Genprex. “We…

TuesdayApr 02, 2024 1:09 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases FY 2023 Financial Report, Corporate Update

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has released financial results for the full year ending Dec. 31, 2023; the company also reported on corporate and clinical development achievement for the year. Highlights of the report included that Berubicin, the company’s lead program, has passed preplanned interim futility analysis milestones with a recommendation to proceed without modification into a potentially pivotal glioblastoma multiforme (“GBM”) study, and enrollment for the Berubicin study has been completed with topline data expected in first half…

TuesdayApr 02, 2024 12:21 pm

QualityStocksNewsBreaks – Zoned Properties Inc. (ZDPY) Refocusing Investment Portfolio to Potentially Unlock Equity

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, is seeking to capitalize on the U.S. cannabis industry’s burgeoning future by targeting commercial properties with the potential to be acquired and rezoned or permitted for specific purposes. “Zoned Properties maintains a portfolio of six investment properties located across Arizona, Michigan and Illinois, with each of its leased properties occupied by commercial cannabis-linked businesses. The company currently enjoys a 100% occupancy rate with a weighted average lease term of over 10 years. In addition to maintaining four properties leased and repurposed as regulated cannabis retail…

TuesdayApr 02, 2024 12:00 pm

QualityStocksNewsBreaks – SUIC Worldwide Holdings Ltd (SUIC) Engages IBN for Corporate Communications Expertise, Enters Strategic Agreement

SUIC Worldwide Holdings (OTC: SUIC), a provider of research and development, venture financing and investment for private and public companies, announced that it has selected IBN, a multifaceted financial news and publishing company for private and public entities, to assist with its corporate communications initiatives. Seeking to enhance and streamline existing processes and establish new and exciting business models, SUIC Worldwide Holdings targets investment in companies operating in the areas of internet of things (“IoT”), cloud computing, mobile payments, big data, blockchain, artificial intelligence and global franchising. As part of the client partner relationship, IBN will generate greater awareness for…

TuesdayApr 02, 2024 11:40 am

QualityStocksNewsBreaks – Astiva Health Setting New Standard for Patient-Centric Care

Astiva Health, a leading provider that specializes in delivering personalized and comprehensive healthcare solutions to diverse communities, is championing a model of care that emphasizes proactive health management and a healthy lifestyle over traditional reactive methods. “At the core of Astiva Health’s innovative approach is the principle of patient-centric care. This method prioritizes the active involvement of patients in their healthcare decisions, ensuring their preferences, needs and values guide their care plans… A critical element in Astiva Health’s strategy is the development of a supportive health community. This community – encompassing healthcare professionals, family, caregivers, and peer groups – provides…

TuesdayApr 02, 2024 10:30 am

Building a Prosperous Future, Zoned Properties Inc.’s (ZDPY) Direct-to-Consumer Design in Cannabis Real Estate

Zoned Properties is a leader in cannabis real estate development, with a sophisticated PropTech stack to spearhead a direct-to-consumer real estate model Zoned Properties reported a net profit of $114,523 during the quarter ended September 30, 2023 ZPDY has listed a property for sale at a price of $16 million, non-dilutive capital that will be used to continue to fund growth The cannabis industry is experiencing explosive growth, but its infrastructure often lags behind. Green Zones – compliant locations and properly permitted real estate – are part and parcel to unlocking the industry's full potential. This focus not only fuels…

TuesdayApr 02, 2024 9:45 am

Correlate Energy Corp. (CIPI) Taps Green Solutions to Help Businesses Economically Develop and Manage Energy Assets under Increased Government Encouragement

Distributed energy solutions company Correlate Energy Corp. is focused on boosting businesses with a clean green focus, helping them to better plan, fund, and manage their building energy profiles Green economic factors are becoming increasingly important to businesses and governments, as evidenced by pollution-reducing measures taken by the federal and state governments, and at the local level as with New York City The most recent measure of that commitment is the March 20 announcement by the EPA to roll out finalized national pollution standards for cars, pickups, and other vehicles Correlate’s strategy includes the development and sale of localized clean…

TuesdayApr 02, 2024 9:00 am

Clene Inc. (NASDAQ: CLNN) Announces Publication of “Protein Corona Composition of Gold Nanocatalysts” in ACS Pharmacology & Translational Science

The publication provides a comprehensive analysis of proteins from human blood plasma that interact with CNM-Au8(R) CNM-Au8 nanocrystals coated with a protein corona are less prone to clumping compared to those without any coating Certain apolipoproteins found on the nanocrystals' surface, which aid in crossing the blood-brain barrier (“BBB”), were identified, suggesting an enhanced delivery mechanism into the brain The findings enrich the understanding of CNM-Au8's mechanism as preparations for a Phase 3 trial for ALS are underway, scheduled for the second half of 2024 Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company…

Site Search

Company Search